Anthony Kirck
Comptroller/Controller/Auditor bij OPTINOSE, INC.
Vermogen: 130 309 $ op 30-04-2024
Actieve functies van Anthony Kirck
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 01-11-2021 | - |
Loopbaan van Anthony Kirck
Eerdere bekende functies van Anthony Kirck
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01-02-2020 | 01-11-2021 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 01-06-2017 | 01-02-2020 |
Opleiding van Anthony Kirck
| Albright College | Undergraduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
| Ierland | 2 |
Operationeel
| Comptroller/Controller/Auditor | 2 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Beurs
- Insiders
- Anthony Kirck
- Ervaring
